European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Apr 20 2026 A major multi-country study has found that WHO-recommended first-line antibiotics for neonatal sepsis are likely to be effective in only one quarter of infections in low- and middle-income countries (LMICs). The findings, presented today at ESCMID Global 2026, highlight the growing impact of antimicrobial resistance (AMR). Neonatal sepsis, a life-threatening infection occurring within the first month of life,

Tag-uri: Medicamente